Xylene Isomerization in a ZSM-5/SS Membrane Reactor

A membrane reactor containing different types of ZSM-5/porous SS membranes was used to perform the xylene isomerization reaction. The parent Na-ZSM-5 layer was synthesized by secondary growth on top of porous stainless steel tubes. The xylene isomerization reaction was carried out at different temperatures in the membrane reactor and in a fixed-bed reactor of identical geometry for comparison. Two different kinds of membranes were prepared by ion exchange: a Pt/H-ZSM-5 catalytic membrane and two Ba-ZSM-5 composites with different Ba²⁺ concentration. The p-xylene production using 100% exchanged Ba-membrane was about 28% higher than the fixed-bed reactor at 370 °C, when m-xylene was fed.     

Preparation and Crystal Structure of KFeCl3 and KFeBr3

The preparation and crystal structures of anhydrous KFeCl₃ and KFeBr₃ are described. X-ray diffraction data obtained at room temperature indicate that the two compounds belong to the orthorhombic system, space group Pnma and z = 4. Unit cell parameters are a = 8.712 Å, b = 3.845 Å, c = 14.15 Å for KFeCl₃ and a = 9.220 Å, b = 4.026 Å, c = 14.899 Å for KFeBr₃. Atomic positions were determined.     

Human immunodeficiency virus infection, Part II

The acceptance of highly active antiretroviral therapy (HAART) among patients and health care providers has had a dramatic impact on the epidemiology and clinical characteristics of many opportunistic infections associated with human immunodeficiency virus (HIV). Previously intractable opportunistic infections and syndromes are now far less common. In addition, effective antibiotic prophylactic therapies have had a profound impact on the risk of patients developing particular infections and on the incidence of these infections overall. Most notable among these are Pneumocystis carinii, disseminated Mycobacterium avium complex, tuberculosis, and toxoplasmosis. Nevertheless, infections continue to cause significant morbidity and mortality among patients who are infected with HIV. The role of HAART in many clinical situations is unquestioned. Compelling data from clinical trials support the use of these therapies during pregnancy to prevent perinatal transmission of HIV. HAART is also recommended for health care workers who have had a "significant" exposure to the blood of an HIV-infected patient. Both of these situations are discussed in detail in this article. In addition, although more controversial, increasing evidence supports the use of HAART during the acute HIV seroconversion syndrome. An "immune reconstitution syndrome" has been newly described for patients in the early phases of treatment with HAART who develop tuberculosis, M avium complex, and cytomegalovirus disease. Accumulating data support the use of hydroxyurea, an agent with a long history in the field of myeloproliferative disorders, for the treatment of HIV. Newer agents, particularly abacavir and adefovir dipivoxil, are available through expanded access protocols, and their roles are being defined and clarified.     

On the Retirement of E. P. Goldfinch, Founder of Radiation Protection Dosimetry

In June of 2004, Eddie Goldfinch will be retiring from his dutiesas Executive Editor of Radiation Protection Dosimetry (RPD).Oxford University Press is publishing the journal, however itshould be noted that Eddie has not completely stopped his publishingactivities or his association with RPD. He will remain as anemeritus member of the Editorial     

Multicast-based inference of network-internal delay distributions

Packet delay greatly influences the overall performance of network applications. It is therefore important to identify causes and locations of delay performance degradation within a network. Existing techniques, largely based on end-to-end delay measurements of unicast traffic, are well suited to monitor and characterize the behavior of particular end-to-end paths. Within these approaches, however, it is not clear how to apportion the variable component of end-to-end delay as queueing delay at each link along a path. Moreover, there are issues of scalability for large networks. In this paper, we show how end-to-end measurements of multicast traffic can be used to infer the packet delay distribution and utilization on each link of a logical multicast tree. The idea, recently introduced in Caceres et al. (1999), is to exploit the inherent correlation between multicast observations to infer performance of paths between branch points in a tree spanning a multicast source and its receivers. The method does not depend on cooperation from intervening network elements; because of the bandwidth efficiency of multicast traffic, it is suitable for large-scale measurements of both end-to-end and internal network dynamics. We establish desirable statistical properties of the estimator, namely consistency and asymptotic normality. We evaluate the estimator through simulation and observe that it is robust with respect to moderate violations of the underlying model.     

Methods for true energy-performance optimization

This paper presents methods for efficient energy-performance optimization at the circuit and micro-architectural levels. The optimal balance between energy and performance is achieved when the sensitivity of energy to a change in performance is equal for all the design variables. The sensitivity-based optimizations minimize energy subject to a delay constraint. Energy savings of about 65% can be achieved without delay penalty with equalization of sensitivities to sizing, supply, and threshold voltage in a 64-bit adder, compared to the reference design sized for minimum delay. Circuit optimization is effective only in the region of about /spl plusmn/30% around the reference delay; outside of this region the optimization becomes too costly either in terms of energy or delay. Using optimal energy-delay tradeoffs from the circuit level and introducing more degrees of freedom, the optimization is hierarchically extended to higher abstraction layers. We focus on the micro-architectural optimization and demonstrate that the scope of energy-efficient optimization can be extended by the choice of circuit topology or the level of parallelism. In a 64-bit ALU example, parallelism of five provides a three-fold performance increase, while requiring the same energy as the reference design. Parallel or time-multiplexed solutions significantly affect the area of their respective designs, so the overall design cost is minimized when optimal energy-area tradeoff is achieved.     

The composite structure of peak 5 in the glow curve of LiF:Mg,Ti (TLD-100): confirmation of peak 5a arising from a locally trapped electron-hole configuration

The hypothesis that glow peak 5a arises from localised e-h capture is confirmed by the following experimental observations: (i) The high conversion efficiency (CE) (CE5a-->4 = 3 +/- 0.5) of peak 5a to peak 4 (a hole-only trap) deduced from detailed Im-Tstop optical bleaching studies at 310 nm compared to the much lower CE of peak 5 (an electron-only trap) (CE5-->4 = 0.0026+/-0.012). (ii) The lack of an increase in the sensitivity of glow peak 5a following 2.6 MeV and 6.8 MeV He ion irradiation in 'sensitised' material compared to the factor two increase in the sensitivity of peak 5; (S/S0)5a = 0.86+/-0.12, compared to (S/S0)5 = 2.0+/-0.2. (iii) The late entry into saturation of the 2.6 MeV and 6.8 MeV He ion TL-fluence response curves for peak 5a compared to peak 5 in sensitised and normal material resulting in the following values for the track radial saturation parameter: (r50)5a = 100+/-20) Angstroms compared to (r50)5 = 380+/-30 Angstroms. (iv) The low value of 0.1 for the 'track-escape' parameter of peak 5a deduced from the Extended Track Interaction Model analysis of He ion TL fluence response compared to order of magnitude greater values for peaks 5 and 5b.